Skip to content

Topic: RNA splicing

Seminar
2 seminars
Seminar · Molecular Biology

Expanding mechanisms and therapeutic targets for neurodegenerative disease

Aaron D. Gitler · Department of Genetics, Stanford University

Thu, Jun 5, 2025 · 14:00 UTC

A hallmark pathological feature of the neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is the depletion of RNA-binding protein TDP-43 from the nucleus of neurons in the brain and spinal cord. A major function of TDP-43 is as a repressor of cryptic exon inclusion during RNA splicing. By re-analyzing RNA-sequencing datasets from human FTD/ALS brains, we discovered dozens of novel cryptic splicing events in important neuronal genes. Single nucleotide polymorphisms in UNC13A are among the strongest hits associated with FTD and ALS in human genome-wi

Seminar · Neuroscience

Mechanisms to medicines in neurodegeneration

Giovann Mallucci · Department of Clinical Neurosciences, University of Cambridge

Tue, Nov 30, 2021 · 15:00 UTC

Dysregulation of protein synthesis both globally and locally in neurons and astrocytes is a key feature of neurodegenerative diseases. Aberrant signalling through the Unfolded Protein Response (UPR) and related Integrated Stress Response (ISR) have become major targets for neuroprotection in these disorders. In addition, other homeostatic mechanisms and stress responses, including the cold shock response, appear to regulate local translation and RNA splicing to control synapse maintenance and regeneration and can also be targeted therapeutically for neuroprotection. We have defined the role of

We use essential cookies to run the site. Optional analytics and public-page session replay help us improve World Wide. Learn more.